Detalles de la búsqueda
1.
Predisposing factors for advanced liver fibrosis in patients with sickle cell disease.
Br J Haematol
; 202(6): 1192-1198, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37438880
2.
Iron Chelators, Such as Deferasirox, When Combined With Hydroxyurea, Provide an Additional Benefit of Iron Chelation in Patients Receiving Chronic Transfusion Therapy.
Hemoglobin
; 46(2): 114-117, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36069257
3.
Acute Chest Syndrome in Sickle Cell Disease: Clinical Presentation and Outcomes. The Experience of a Single Thalassemia and Sickle Cell Unit in a University Hospital.
Hemoglobin
; 45(5): 303-308, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34814798
4.
Severity of heart failure and health-related quality of life in beta-thalassemia patients: a cross-sectional study.
Ann Hematol
; 99(9): 2037-2046, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32436014
5.
Clinical significance of mutational variants in beta and alpha genes in patients with hemoglobinopathies from two large Greek centers: a complex interplay between genotype and phenotype.
J Mol Med (Berl)
; 101(9): 1073-1082, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37420139
6.
Stratification of ßSß+ Compound Heterozygotes Based on L-Glutamine Administration and RDW: Focusing on Disease Severity.
Antioxidants (Basel)
; 12(11)2023 Nov 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38001835
7.
Steroid-induced hypocalcaemia with tetany in a patient with hypoparathyroidism.
BMJ Case Rep
; 20142014 Nov 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-25406219
Resultados
1 -
7
de 7
1
Próxima >
>>